Growth Hormone Therapy: Safety

ISSN 1662-4009 (online)

An indispensable reference tool endorsed by the European Society for Paediatric Endocrinology

Previous issue | Volume 18 | ESPEYB18 | Next issue

Yearbook of Paediatric Endocrinology 2021

4. Growth and Growth Factors

Previous section
Important for clinical practice

Table of contents

Next section
New Perspectives

ey0018.4-5 | Growth Hormone Therapy: Safety

4.5. Long-term safety of growth hormone treatment in childhood: two Large observational studies: nordiNet IOS and ANSWER

ey0018.4-6 | Growth Hormone Therapy: Safety

4.6. Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study

ey0018.4-7 | Growth Hormone Therapy: Safety

4.7. Association of childhood growth hormone treatment with long-term cardiovascular morbidity

ey0018.4-8 | Growth Hormone Therapy: Safety

4.8. Longitudinal study on metabolic health in adults SGA during 5 years after GH with or without 2 years of GnRHa treatment

ESPE Yearbook of Paediatric Endocrinology
ISSN 1662-4009 (Online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Yearbook of Paediatric Endocrinology